首都医科大学附属北京天坛医院子宫内膜异位症推荐专家

简介:

首都医科大学附属北京天坛医院，始建于1956年，是一所集医、教、研、防为一体的三级甲等综合医院，以神经科学集群为特色，尤其在神经外科学、神经病学领域享有盛誉。医院设有国家神经系统疾病临床医学研究中心，是国家医师资格考试实践技能考试基地，在神经系统疾病治疗方面具有丰富的临床经验。针对子宫内膜异位症这一女性常见妇科疾病，医院凭借精湛的医术和先进的诊疗设备，为患者提供个性化、全方位的治疗方案，助力患者重获健康。北京天坛医院，致力于为患者提供高品质的医疗服务，是您战胜疾病的坚强后盾。子宫内膜异位症（endometriosis）是指有活性的内膜细胞种植在子宫内膜以外的位置而形成的一种女性常见妇科疾病。内膜细胞本该生长在子宫腔内,但由于子宫腔通过输卵管与盆腔相通,因此使得内膜细胞可经由输卵管进入盆腔异位生长。，子宫内膜种植,免疫防御功能缺陷,遗传与体质的因素,内分泌功能失调，盆腔，子宫内膜异位症的治疗方案,因病情的轻重,患者的年龄和生育情况而有所不同。如病情较重,或表现为重的痛经,或盆腔检查发现有肯定的内膜异位结节,就必须采取药物或手术治疗，卵巢恶性肿瘤、盆腔炎性肿块和子宫腺肌病，尽量少吃含有雌激素的食物,如大豆、洋葱、黑米、小麦等，B型超声检查,腹腔镜检查,实验室检查，。

true 赵卫红主任医师

三级甲等首都医科大学附属北京天坛医院

好评率：99% 接诊量：1235 平均响应：30分钟

卵巢肿瘤，子宫肌瘤，盆腔子宫内膜异位症，子宫腺肌症，子宫颈癌，子宫内膜癌，卵巢癌，子宫脱垂，阴道前后壁脱垂等各种疾病的诊断及治疗。尤其擅长妇科内窥镜技术包括腹腔镜和宫腔镜技术诊断及治疗不孕症，卵巢良性肿瘤，子宫肌瘤，子宫腺肌症，盆腔子宫内膜异位症，宫外孕，异常子宫出血，绝经后出血，宫颈病变，子宫粘连，子宫纵隔，粘膜下子宫肌瘤，子宫内膜息肉等各种疾病。

接诊医生：

2024-09-06 11:42:45

科普文章

子宫内膜异位症的类型与卵巢癌风险

以下内容来源于pubmed。

Endometriosis Typology and Ovarian Cancer Risk

Abstract

Importance: Endometriosis has been associated with an increased risk of ovarian cancer; however, the associations between endometriosis subtypes and ovarian cancer histotypes have not been well-described.

Objective: To evaluate the associations of endometriosis subtypes with incidence of ovarian cancer, both overall and by histotype.

Design, setting, and participants: Population-based cohort study using data from the Utah Population Database. The cohort was assembled by matching 78 893 women with endometriosis in a 1:5 ratio to women without endometriosis.

Exposures: Endometriosis cases were identified via electronic health records and categorized as superficial endometriosis, ovarian endometriomas, deep infiltrating endometriosis, or other.

Main outcomes and measures: Estimated adjusted hazard ratios (aHRs), adjusted risk differences (aRDs) per 10 000 women, and 95% CIs for overall ovarian cancer, type I ovarian cancer, and type II ovarian cancer comparing women with each type of endometriosis with women without endometriosis. Models accounted for sociodemographic factors, reproductive history, and past gynecologic operations.

Results: In this Utah-based cohort, the mean (SD) age at first endometriosis diagnosis was 36 (10) years. There were 597 women with ovarian cancer. Ovarian cancer risk was higher among women with endometriosis compared with women without endometriosis (aHR, 4.20 [95% CI, 3.59-4.91]; aRD, 9.90 [95% CI, 7.22-12.57]), and risk of type I ovarian cancer was especially high (aHR, 7.48 [95% CI, 5.80-9.65]; aRD, 7.53 [95% CI, 5.46-9.61]). Ovarian cancer risk was highest in women with deep infiltrating endometriosis and/or ovarian endometriomas for all ovarian cancers (aHR, 9.66 [95% CI, 7.77-12.00]; aRD, 26.71 [95% CI, 20.01-33.41]), type I ovarian cancer (aHR, 18.96 [95% CI, 13.78-26.08]; aRD, 19.57 [95% CI, 13.80-25.35]), and type II ovarian cancer (aHR, 3.72 [95% CI, 2.31-5.98]; aRD, 2.42 [95% CI, -0.01 to 4.85]).

Conclusions and relevance: Ovarian cancer risk was markedly increased among women with ovarian endometriomas and/or deep infiltrating endometriosis. This population may benefit from counseling regarding ovarian cancer risk and prevention and could be an important population for targeted screening and prevention studies.